NPCE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Neuropace Inc (NPCE) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock has strong revenue growth, positive analyst sentiment, and a favorable technical setup, making it a suitable choice for long-term holding despite short-term financial losses.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 72.226, and moving averages are converging, suggesting a potential continuation of the upward trend. The stock is trading near its resistance level (R2: 14.883), showing strength with a recent price increase of 4.12% in regular trading and 1.95% post-market.
Analysts maintain a Buy/Overweight rating with a price target of $19, implying significant upside potential.
Revenue growth of 23.86% YoY in Q4 2025 reflects strong operational performance.
Gross margin improved to 77.4%, indicating better cost efficiency.
Net income dropped by 48.02% YoY, and EPS declined by 55.56%, reflecting ongoing profitability challenges.
No significant hedge fund or insider trading activity, indicating neutral sentiment from key stakeholders.
In Q4 2025, revenue increased by 23.86% YoY to $26.59M, showcasing strong growth. However, net income fell to -$2.73M, down 48.02% YoY, and EPS dropped to -$0.08, down 55.56% YoY. Gross margin improved to 77.4%, up 2.64% YoY, indicating operational efficiency gains.
Analysts are positive on NPCE, with Wells Fargo and H.C. Wainwright maintaining Buy/Overweight ratings and a price target of $19. Analysts expect core revenue growth of 20%-22% in 2026, indicating confidence in the company's growth trajectory.
